Last updated: April 2, 2025
Sponsor: Abbott Medical Devices
Overall Status: Active - Recruiting
Phase
N/A
Condition
Heart Defect
Cardiac Disease
Heart Disease
Treatment
Aveir AR Leadless Pacemaker
Single-chamber atrial transvenous pacemaker
Clinical Study ID
NCT06100770
ABT-CIP-CL1021378
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Medicare beneficiaries implanted with an Aveir AR leadless pacemaker on or after thestudy start date (i.e., the date of Aveir AR market approval) will be included inthe study. OR
Medicare beneficiaries implanted with a full system (e.g. lead and generator) singlechamber atrial transvenous pacemaker on or after the study start date
Exclusion
Exclusion Criteria:
- None
Study Design
Total Participants: 586
Treatment Group(s): 2
Primary Treatment: Aveir AR Leadless Pacemaker
Phase:
Study Start date:
January 18, 2024
Estimated Completion Date:
January 31, 2031
Study Description
Connect with a study center
Abbott
Sylmar, California 91342
United StatesActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.